These receptors include Pdgfrb, Fgfr2, Ddr2, Ryk, and Lrp1, many of which show altered expression in NASH livers, suggesting their functions in accepting signals and modulating cell fate switch of HSCs during NASH progression. The gene discussed is DDR2; the disease is metabolic dysfunction-associated steatohepatitis.